Publicaciones en colaboración con investigadores/as de Università degli Studi di Siena (7)

2020

  1. The specific PKC-α inhibitor chelerythrine blunts costunolide-induced eryptosis

    Apoptosis, Vol. 25, Núm. 9-10, pp. 674-685

2017

  1. Comparative Analysis of the Neurochemical Profile and MAO Inhibition Properties of N-(Furan-2-ylmethyl)-N-methylprop-2-yn-1-amine

    ACS Chemical Neuroscience, Vol. 8, Núm. 5, pp. 1026-1035

  2. Multitarget compounds bearing tacrine- and donepezil-like structural and functional motifs for the potential treatment of Alzheimer's disease

    Progress in Neurobiology, Vol. 151, pp. 4-34

2016

  1. Donepezil-like multifunctional agents: Design, synthesis, molecular modeling and biological evaluation

    European Journal of Medicinal Chemistry, Vol. 121, pp. 864-879

2015

  1. Development of HuperTacrines as non-toxic, cholinesterase inhibitors for the potential treatment of Alzheimer’s disease

    Mini-Reviews in Medicinal Chemistry, Vol. 15, Núm. 8, pp. 648-658

2008

  1. Anti-apoptotic effect of Mao-B inhibitor PF9601N [N-(2-propynyl)-2-(5- benzyloxy-indolyl) methylamine] is mediated by p53 pathway inhibition in MPP+-treated SH-SY5Y human dopaminergic cells

    Journal of Neurochemistry, Vol. 105, Núm. 6, pp. 2404-2417

2007

  1. CYP-dependent metabolism of PF9601N, a new monoamine oxidase-B inhibitor, by C57BL/6 mouse and human liver microsomes.

    Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Société canadienne des sciences pharmaceutiques, Vol. 10, Núm. 4, pp. 473-485